查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386215

全球活細胞成像市場：趨勢、預測和競爭分析（~2030 年）

Live Cell Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

活細胞成像趨勢和預測

預計到2030年，全球活細胞成像市場規模將達到約58.7億美元，2024年至2030年年複合成長率為11.1%。這個市場的主要促進因素是在藥物研發中擴大採用高內涵篩選技術、增加癌症發生率以及增加政府對細胞研究的資助。全球活細胞成像市場的未來可能包括細胞生物學、幹細胞、發育生物學和藥物研發市場的商機。

活細胞成像市場洞察

Lucintel 預測，在預測期內，設備仍將是最大的細分市場，因為它有助於提供有關細胞和組織功能基本性質的重要見解。

在這個市場中，幹細胞可能仍然是最大的細分市場，因為它們具有獨特的自我更新和分化成不同細胞類型的能力，導致它們在細胞替代和組織工程療法中的應用越來越廣泛。

由於醫療基礎設施和研發活動投資增加，以及這些成像技術在精準醫學和藥物研發應用中的採用不斷增加，預計亞太地區在預測期內將出現最高成長。

市場規模/估計：活細胞成像的貨幣估計市場金額（10 億美元）

趨勢和預測分析：各細分市場和地區的市場趨勢（2018-2023）和預測（2024-2030）

細分分析：按產品和服務、技術、應用、最終用途和地區等各個細分市場的金額（十億美元）估算活細胞成像市場。

區域分析：北美、歐洲、亞太地區和世界其他地區的活細胞成像市場細分

成長機會：按產品/服務、技術、應用、最終用途和地區分類的活細胞成像市場成長機會分析

策略分析：活細胞成像市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球活細胞影像市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球活細胞成像市場趨勢（2018-2023）與預測（2024-2030）
  • 全球活細胞成像市場：按產品和服務分類
    • 裝置
    • 消耗品
    • 軟體
    • 服務
    • 其他
  • 全球活細胞成像市場：依技術分類
    • Time-Lapse Microscopy
    • Fluorescence Resonance Energy Transfer
    • Fluorescence Recovery After Photobleaching
    • High Content Screening
    • 其他
  • 全球活細胞成像市場：依應用分類
    • 細胞生物學
    • 幹細胞
    • 發育生物學
    • 藥物研發
    • 其他
  • 全球活細胞成像市場：依最終用途分類
    • 製藥和生物技術公司
    • 學術研究所
    • 合約研究組織
    • 其他

第4章 市場趨勢與預測分析：按地區（2018-2030）

  • 全球活細胞成像市場：按地區
  • 北美活細胞成像市場
  • 歐洲活細胞成像市場
  • 亞太地區活細胞影像市場
  • 其他地區活細胞成像市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球活細胞成像市場按產品和服務的成長機會
    • 全球活細胞成像市場的技術成長機會
    • 全球活細胞成像市場成長機會（按應用）
    • 按最終用途分類的全球活細胞成像市場成長機會
    • 全球活細胞成像市場按地區成長機會
  • 全球活細胞成像市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球活細胞成像市場的產能
    • 全球活細胞成像市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Danaher
  • ZEISS
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • CytoSMART Technologies
簡介目錄

Live Cell Imaging Trends and Forecast

The future of the global live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets. The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030 with a CAGR of 11.1% from 2024 to 2030. The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

A more than 150-page report is developed to help in your business decisions.

Live Cell Imaging by Segment

The study includes a forecast for the global live cell imaging by product & service, technology, application, end use, and region.

Live Cell Imaging Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Software
  • Services
  • Others

Live Cell Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Time-Lapse Microscopy
  • Fluorescence Resonance Energy Transfer
  • Fluorescence Recovery After Photobleaching
  • High Content Screening
  • Others

Live Cell Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery
  • Others

Live Cell Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organisations
  • Others

Live Cell Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Live Cell Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies live cell imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the live cell imaging companies profiled in this report include-

  • Danaher
  • Zeiss
  • Nikon Corporation
  • Olympus Corporation
  • Perkinelmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • Cytosmart Technologies

Live Cell Imaging Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Within this market, stem cell will remain the largest segment due to its increasing adoption in cell replacement and tissue engineering therapies owing to their unique abilities to self-renew and differentiate into diverse cell types.

APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Features of the Global Live Cell Imaging Market

Market Size Estimates: Live cell imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Live cell imaging market by various segments, such as by product & service, technology, application, end use and region in terms of($B).

Regional Analysis: Live cell imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, technologies, applications, end uses, and regions for the live cell imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the live cell imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the live cell imaging market size?

Answer: The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030.

Q.2 What is the growth forecast for live cell imaging market?

Answer: The global live cell imaging market is expected to grow with a CAGR of 11.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the live cell imaging market?

Answer: The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

Q4. What are the major segments for live cell imaging market?

Answer: The future of the live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets.

Q5. Who are the key live cell imaging market companies?

Answer: Some of the key live cell imaging companies are as follows:

  • Danaher
  • ZEISS
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • CytoSMART Technologies

Q6. Which live cell imaging market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Q7. In live cell imaging market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the live cell imaging market by product & service (instruments, consumables, software, services, and others), technology (time-lapse microscopy, fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high content screening, and others), application (cell biology, stem cells, developmental biology, drug discovery, and others), end use (pharmaceutical & biotechnology companies, academic and research institutes, contract research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Live Cell Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Live Cell Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Live Cell Imaging Market by Product & Service
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Software
    • 3.3.4: Services
    • 3.3.5: Others
  • 3.4: Global Live Cell Imaging Market by Technology
    • 3.4.1: Time-Lapse Microscopy
    • 3.4.2: Fluorescence Resonance Energy Transfer
    • 3.4.3: Fluorescence Recovery After Photobleaching
    • 3.4.4: High Content Screening
    • 3.4.5: Others
  • 3.5: Global Live Cell Imaging Market by Application
    • 3.5.1: Cell Biology
    • 3.5.2: Stem Cells
    • 3.5.3: Developmental Biology
    • 3.5.4: Drug Discovery
    • 3.5.5: Others
  • 3.6: Global Live Cell Imaging Market by End Use
    • 3.6.1: Pharmaceutical & Biotechnology Companies
    • 3.6.2: Academic and Research Institutes
    • 3.6.3: Contract Research Organisations
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Live Cell Imaging Market by Region
  • 4.2: North American Live Cell Imaging Market
    • 4.2.2: North American Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.3: European Live Cell Imaging Market
    • 4.3.1: European Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.3.2: European Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.4: APAC Live Cell Imaging Market
    • 4.4.1: APAC Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.4.2: APAC Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.5: ROW Live Cell Imaging Market
    • 4.5.1: ROW Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.5.2: ROW Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Live Cell Imaging Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Live Cell Imaging Market by Technology
    • 6.1.3: Growth Opportunities for the Global Live Cell Imaging Market by Application
    • 6.1.4: Growth Opportunities for the Global Live Cell Imaging Market by End Use
    • 6.1.5: Growth Opportunities for the Global Live Cell Imaging Market by Region
  • 6.2: Emerging Trends in the Global Live Cell Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Live Cell Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Live Cell Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Danaher
  • 7.2: ZEISS
  • 7.3: Nikon Corporation
  • 7.4: Olympus Corporation
  • 7.5: PerkinElmer
  • 7.6: Sartorius
  • 7.7: Agilent Technologies
  • 7.8: Thermo Fisher Scientific
  • 7.9: Etaluma
  • 7.10: CytoSMART Technologies